-Reuters
Nature Medicine Publishes Results From Pivotal Phase 3 LAVENDER Study Evaluating DAYBUE Efficacy And Safety In Patients With Rett Syndrome
-- Statistically significant differences demonstrated between DAYBUE™ and placebo on efficacy endpoints relevant to Rett syndrome suggest treatment potentially capable of modifying core symptoms consistent